R

Replimune Group

Develops oncolytic viral immunotherapies for cancer

Senior Quality Control Analyst

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeAbingdon, UKNo salary listed

About the Job

Requirements

  • A degree in Chemistry, Biochemistry, or another related science.
  • At least 3 years of laboratory-based experience in a similar environment.
  • Competent analytical skills and attention to detail.
  • Understanding of Good Manufacturing Practice requirements.
  • Computer literacy, including Microsoft Word and Excel.
  • Good communication and organizational skills.
  • Ability to work independently and collaboratively as part of a team.

Responsibilities

  • Perform routine and non-routine quality control testing of samples according to Standard Operating Procedures.
  • Maintain cell lines by revival and passaging at set intervals.
  • Receive quality control samples and materials and maintain inventory.
  • Perform routine equipment maintenance and troubleshooting.
  • Lead the introduction of new equipment and participate in validation activities.
  • Write, update, or review Standard Operating Procedures, protocols, and forms.
  • Participate in quality control method transfers, validation, and stability activities.
  • Follow current Good Manufacturing Practice and Good Documentation Practice requirements.
  • Perform general laboratory tasks, including housekeeping, supply inventory, and ordering supplies.
  • Write deviations, Corrective and Preventive Actions, and change controls related to quality control, and assist with investigations of out-of-specification and out-of-trend results.
  • Become a method trainer and train junior team members as required.
  • Assist with internal and regulatory agency audits and inspections.
  • Ensure training records remain compliant with Good Manufacturing Practice requirements.

About the Company

Replimune Group

Develops oncolytic viral immunotherapies for cancer

Replimune develops cancer therapies that use engineered viruses (oncolytic immunotherapies) to attack tumors. These treatments selectively infect cancer cells, causing their destruction, and at the same time stimulate the immune system to recognize and fight tumors. By combining multiple methods of action, Replimune aims to boost the effectiveness of existing immune checkpoint inhibitors and create a stronger anti-tumor response. The company focuses on research, development, and clinical testing, and plans to earn revenue through partnerships, licensing, and eventual sales of approved therapies. Its goal is to deliver workable cancer treatments by validating safety and efficacy in clinical trials and bringing these therapies to patients with various cancers.

Company size
201-500
Company stage
IPO
Headquarters
Woburn, MA
Founded
2015

Recently Posted Jobs

Explore more opportunities at Replimune Group

See more jobs